TABLE 3.
In vitro efficacy of SLF peptides against Staphylococcus aureus strain ATCC 29213
| Peptide | MIC (μM) |
|---|---|
| ORB | >100 |
| cORB | >100 |
| ORB2k | >100 |
| cORB2k | >100 |
| pYR | 50 |
| cpYR | 75 |
| Rana-E | 100 |
| Rana-T | 100 |
| oSFTI-1 | >100 |
| SFTI-1 | >100 |
| Gentamicin | 48 |
In vitro efficacy of SLF peptides against Staphylococcus aureus strain ATCC 29213
| Peptide | MIC (μM) |
|---|---|
| ORB | >100 |
| cORB | >100 |
| ORB2k | >100 |
| cORB2k | >100 |
| pYR | 50 |
| cpYR | 75 |
| Rana-E | 100 |
| Rana-T | 100 |
| oSFTI-1 | >100 |
| SFTI-1 | >100 |
| Gentamicin | 48 |